Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M J Burt

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
The New Zealand Medical Journal|September 23, 1992
Viral hepatitis in the Christchurch communityB A Chapman, D J Hann, M I Schousboe, et al.
The New Zealand Medical Journal|April 25, 2000
Gallstone prevalence in Christchurch: risk factors and clinical significanceB A Chapman, C M Frampton, I R Wilson, et al.
The New Zealand Medical Journal|January 7, 1998
Molecular analysis of HLA-H gene mutations in New Zealand patients with haemochromatosisM J Burt, J D Upton, I M Morison, et al.
The New Zealand Medical Journal|December 14, 1994
Investigation of subjects with abnormal iron studies: role of the hepatic iron indexB A Chapman, D M Horton, M J Burt, et al.
DNA Sequence : the Journal of DNA Sequencing and Mapping|January 1, 1997
Isolation and characterisation of cosmids to intervals within a 4.5Mb region at 6p21.3E C Jazwinska, L M Cullen, A Zournazi, et al.
Digestive Diseases and Sciences|March 25, 1998
Gallbladder volume: comparison of diabetics and controlsB A Chapman, T M Chapman, C M Frampton, et al.
Alimentary Pharmacology & Therapeutics|August 28, 2003
Thiopurine S-methyltransferase (TPMT) genotype does not predict adverse drug reactions to thiopurine drugs in patients with inflammatory bowel diseaseR B Gearry, M L Barclay, M J Burt, et al.
Internal Medicine Journal|July 18, 2001
Influence of haemochromatosis gene mutations on treatment outcomes in patients with hepatitis CB A Chapman, M J Burt, C M Frampton, et al.
The Australian and New Zealand Journal of Surgery|January 1, 1997
37 kBq 14C-urea breath test and gastric biopsy analyses of H. pylori infectionR A Allardyce, B A Chapman, A B Tie, et al.
The New Zealand Medical Journal|March 22, 1995
Treatment of chronic hepatitis C with interferon alphaA G Ross, M J Burt, L C Jennings, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
The New Zealand Medical Journal|September 23, 1992
Viral hepatitis in the Christchurch communityB A Chapman, D J Hann, M I Schousboe, et al.
The New Zealand Medical Journal|April 25, 2000
Gallstone prevalence in Christchurch: risk factors and clinical significanceB A Chapman, C M Frampton, I R Wilson, et al.
The New Zealand Medical Journal|January 7, 1998
Molecular analysis of HLA-H gene mutations in New Zealand patients with haemochromatosisM J Burt, J D Upton, I M Morison, et al.
The New Zealand Medical Journal|December 14, 1994
Investigation of subjects with abnormal iron studies: role of the hepatic iron indexB A Chapman, D M Horton, M J Burt, et al.
DNA Sequence : the Journal of DNA Sequencing and Mapping|January 1, 1997
Isolation and characterisation of cosmids to intervals within a 4.5Mb region at 6p21.3E C Jazwinska, L M Cullen, A Zournazi, et al.
Digestive Diseases and Sciences|March 25, 1998
Gallbladder volume: comparison of diabetics and controlsB A Chapman, T M Chapman, C M Frampton, et al.
Alimentary Pharmacology & Therapeutics|August 28, 2003
Thiopurine S-methyltransferase (TPMT) genotype does not predict adverse drug reactions to thiopurine drugs in patients with inflammatory bowel diseaseR B Gearry, M L Barclay, M J Burt, et al.
Internal Medicine Journal|July 18, 2001
Influence of haemochromatosis gene mutations on treatment outcomes in patients with hepatitis CB A Chapman, M J Burt, C M Frampton, et al.
The Australian and New Zealand Journal of Surgery|January 1, 1997
37 kBq 14C-urea breath test and gastric biopsy analyses of H. pylori infectionR A Allardyce, B A Chapman, A B Tie, et al.
The New Zealand Medical Journal|March 22, 1995
Treatment of chronic hepatitis C with interferon alphaA G Ross, M J Burt, L C Jennings, et al.
Pageof 4